Daiwa Securities Group Inc. Biotechnology

Daiwa Securities Group Inc.

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
TERN Terns Pharmaceuticals, Inc.	$224M	$1,000 0.0% of portfolio	151	Q4 2022 New
QURE Uni Qure N.V.	$281M	$1,000 0.0% of portfolio	158	Q3 2021 Added 88.1%
VNDA Vanda Pharmaceuticals Inc.	$294M	$1,000 0.0% of portfolio	191	Q3 2021 Added 59.17%
VYGR Voyager Therapeutics, Inc.	$223M	$1,000 0.0% of portfolio	201	Q1 2024 New
XERS Xeris Biopharma Holdings, Inc.	$469M	$1,000 0.0% of portfolio	404	Q1 2022 Added 296.08%
ZNTL Zentalis Pharmaceuticals, Inc.	$207M	$1,000 0.0% of portfolio	212	Q2 2022 Added 60.61%
ALXO Alx Oncology Holdings Inc	$61.5M	$0 0.0% of portfolio	138	Q3 2021 Added 74.68%
BLUE Bluebird Bio, Inc.	$29.3M	$0 0.0% of portfolio	333	Q2 2024 Reduced 97.95%
CRBU Caribou Biosciences, Inc.	$134M	$0 0.0% of portfolio	176	Q4 2021 New
CHRS Coherus Bio Sciences, Inc.	$97.9M	$0 0.0% of portfolio	262	Q3 2021 Added 94.07%
FULC Fulcrum Therapeutics, Inc.	$206M	$0 0.0% of portfolio	138	Q3 2021 Added 165.38%
RAPT Rapt Therapeutics, Inc.	$36.5M	$0 0.0% of portfolio	101	Q3 2021 Added 119.57%
VTYX Ventyx Biosciences, Inc.	$150M	$0 0.0% of portfolio	228	Q4 2022 New

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.